Source BioScience Cambridge Office

Source BioScience expands diagnostic capabilities with acquisition of Cambridge Clinical Laboratories

Source BioScience UK Ltd has completed the acquisition of Cambridge Clinical Laboratories (CCL), establishing a more comprehensive clinical diagnostics portfolio that aims to streamline testing services across the research and clinical spectrum. The transaction, announced on 10 April 2025, will see CCL staff and assets relocated to new clinical laboratory facilities at Source BioScience’s Vision […]

Scherm­afbeelding 2025 04 23 om 12.21.42

Nova Biomedical | Next Generation Hospital Glucose/Ketone Meter

Next Generation Hospital Glucose/Ketone Meter

Scherm­afbeelding 2025 04 23 om 12.21.12

Diasys | High quality solutions for reliable cardiovascular risk assessment

High quality solutions for reliable cardiovascular risk assessment HDL-c direct FS LDL-c direct FS

Scherm­afbeelding 2025 04 23 om 12.22.59

HemoCell | Hemostasis automation that works on so many levels

Hemostasis automation that works on so many levels.

AdobeStock 172707757

Hidden cellular gateways offer new approach for drug development

Computer simulations reveal previously unknown access points in cell membrane proteins that could lead to more targeted therapeutic approaches for a range of conditions.

AdobeStock 262643263

New comprehensive atlas aims to optimise gene therapy delivery

Researchers have created a detailed map of adeno associated virus distribution in mice to improve targeting efficiency and reduce off-target effects in gene therapy applications.

Scherm­afbeelding 2025 04 23 om 11.58.02

Increased confidence and efficiency with improved infectious disease diagnostics

For both the patient journey and laboratory efficiency, when diagnosing infectious diseases it is important to get it right and to get it right the first time. CLI caught up with Dr Gaiane Demirdjian, Director of Research & Development at Beckman Coulter Diagnostics, to find out more about how their new line of infectious disease […]

Scherm­afbeelding 2025 04 23 om 11.34.04

Bone turnover markers for diagnostics and therapy monitoring

by Dr Jacqueline Gosink Bone turnover markers (BTMs) provide a non-invasive method to assess bone remodelling – the process by which old bone tissue is removed and replaced. Measurement of BTMs supports diagnosis of metabolic bone diseases, such as Paget’s disease, and is a useful aid for monitoring therapy responses in osteoporosis. Panels of peptide […]

Prebiomics setup

Advancing microbiome research with easier NGS by combining walk-away liquid handling and automated magnetic separation

by Dr Dagmara Lewandowska Peri-implantitis and mucositis are common inflammatory microbial-biofilm diseases affecting tissues surrounding dental implants. Understanding the human oral micro­biome may hold the key to developing tailored and highly effective personalized treatments for these diseases. Liquid-handling automation, combined with magnetic bead separation, enables reliable, high-throughput next-generation sequencing library preparation for this crucial microbiome […]

AdobeStock 206036382

Diagnosis of acute periprosthetic joint infections in reduced incubation time

With an increasingly elderly population, joint replacement surgery is being performed more and more often. Infection around the prosthesis is becoming a more common reason for revision surgery and appropriate antibiotic treatment benefits from accurate diagnosis of the pathogen(s) involved. Current protocols use a standard 10- to 14-day incubation period but a recent publication has […]